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Summary 
 
Accurate neuronal and vascular growth during 
development is critical for an organism’s function and 
survival. Neurons, however, would not grow into a 
spinal cord, nor would endothelial cells form vascular 
tissue, if not for molecular guidance signals. These cells 
are blind to the fate of their growth. Two decades ago, 
my lab, with numerous collaborators, began the process 
of elucidating multiple chemotropic proteins expressed 
in mouse models of the developing nervous system. 
Their presence selectively attracts and repels axons to 
guide their growth. These chemotropic factors play dual 
roles depending on the receptor to which they bind and 
the interactions between these receptors. In tracking the 
unique growth pathway of commissural axons, we 
characterized the activity of five receptor-ligand 
complexes. We showed neuron attraction was mediated 
by DCC-Netrin and Rig-1-Slit complexes, and repulsion 
was mediated by Unc5-Netrin, Robo-Slit, and Neuropilin-
Semaphorin complexes. Additionally, we learned that 
classical morphogens, such as Wnt and Shh, also 
function as chemoattractants. Most recently, we have 
found that several of these chemotropic factors, such as 
Netrin and Semaphorin, play parallel roles in guiding 
vascular growth. My current research aims to expose 
the extent of this parallel and apply this knowledge to 
design therapies promoting neural regeneration after 
injury, as well as inhibiting tumor angiogenesis.  
 
Introduction 
 
The guidance of neuronal and vascular growth is essential to 
proper development of an organism. The molecular signals 
responsible for this guidance were once, however, a mystery 
to the scientific community. My research over the last twenty 
years has transformed that century old textbook void into a 
wealth of knowledge. 
Upon earning my doctorate in physiology at 
University College London in 1987, I returned to the U.S. to 
complete my postdoctoral fellowship at Columbia University 
in collaboration with Jane Dodd and Thomas Jessell, whom 
studied the molecular events regulating the early 
development of the mammalian central nervous system 
(CNS). Particularly, the embryonic mouse spinal cord 
provided an ideal model for assessing the growth of 
numerous populations of neurons extending their axons 
throughout the developing organism. Among these axon 
subtypes, we began studying the growth of commissural 
axons. These differentiated axons follow a stereotyped path 
from the dorsal spinal cord towards the ventral midline where 
they cross the commissure and extend their branches 
rostrally without ever re-crossing the commissure. Our initial 
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research showed that the floor plate of the neural tube 
controls dorsoventral patterning of neuron types during 
embryonic development, including commissural neurons (1). 
More specifically, we found the floor plate secretes a 
diffusible factor that orients commissural axon growth in vitro 
by acting as a chemoattractant (2, 3).  
In 1991, I set out to identify that chemoattractive 
factor. I made the move to University of California, San 
Francisco where I began teaching and researching as an 
investigator for the Howard Hughes Medical Institute at 
Stanford. There, in collaboration with close colleagues Corey 
Goodman and Thomas Kidd, we separated and identified the 
attractive and repulsive ligand-receptor complexes 
responsible for commissural axon guidance. Additionally, we 
characterized the crosstalk that occurs between these 
complexes on the growing axon, at different landmarks of 
their growth.  
When I was offered my current position as Senior 
Vice President of Genentech in 2003, the focus of my 
research expanded to meet the biotherapeutic visions 
embodied by the company. Here, I have applied the 
discoveries of neuronal chemotropic factors to vascular 
tissue growth and shown them to play parallel roles between 
these tissues. Furthermore, in search for a treatment for 
neurodegenerative diseases and neural injury, I have 
investigated the controversial potential for CNS regeneration 
by manipulating expression of the neuronal growth inhibitory 
molecule, Nogo. 
Neuronal and vascular tissue alike are blind to the 
fate of their growth. I have been privileged to discover some 
of the molecular factors guiding these fates. Almost certainly, 
many more remain undiscovered, and, with luck, future 
research will reveal them.  Ultimately, knowledge of these 
factors may then guide treatment of relevant neural and 
vascular disorders, such as Alzheimer’s disease and tumor 
angiogenesis. In this paper, I will tell the tale of commissural 
axon growth through our discovery of these chemotropic 
factors, show their parallels to vascular tissue growth, and 
express my outlook on CNS regeneration.  
 
Commissural Axon Guidance 
 
The Birth of Chemotropic Factors: Netrin 
In 1994, after three years of publishing nothing but reviews 
on axon guidance, myself, Tim Kennedy and other 
colleagues purified, from embryonic chick brain extracts, the 
floor plate derived chemoattractant Drs. Jessel, Dodd, and I 
previously discovered. We christened them netrins,; the root 
“netr” originates from the Sanskrit language, and means 
“one who guides” (4). The netrins came in two isoforms, 
Netrin -1 and -2. They are homologous to the Caenorhabditis 
elegans protein UNC-6, which is similarly required for growth 
cone guidance and mesodermal cell migration in the 
developing nematode (4). Hybridization of the embryonic rat 
spinal cord with netrin-1 and -2 riboprobes confirmed that 
their expression occurs at the ventral midline floor plate (5). 
Moreover, the diffusion of netrin-1 in the developing rat 
spinal cord forms a protein gradient emanating from the floor 
plate (6). We also found that expression of diffusible 
recombinant netrin-1 and -2 by cells in vitro was sufficient to 
elicit commissural axon outgrowth from cultured rat dorsal 
spinal cord explants (4,5). To fortify evidence for netrin as a 
chemoattractant, we developed a homozygous netrin-1 
knockout mouse line, in which the floor plate failed to cause 
commissural axon outgrowth (7). Still, we had no notion of 
73 
 
 
Figure 1. The Role of Chemotropic Factors in Guiding Commissural Axons. A rat model was used to track the path of commissural 
axon growth through the embryonic spinal cord and identify the influence of chemotropic factors at steps along this path. (1) Diffusible Netrin-1 and Shh 
gradient from fp directs cm growth from the dorsal sc towards the ventral commissure through respective cm DCC and Smo receptor expression. (2) 
Lateroventral expression of Unc5b netrin receptor on neurons outside cm path repels them from the commissure. (3) Rig-1 expression on pre-crossing 
cm prevents premature sensitivity to the Slit chemorepellant expressed ventrally. (4) Increased post-crossing cm expression of Robo-1 & -2 sensitizes 
axons to Slits chemorepellent activities, preventing axons from reentering the commissure. (5) Increased Neuropilin-2 expression on post-crossing cm 
sensitizes them to fp Semaphorin3 expression to repel axons from the commissure and guide them rostrally. (6) Wnt protein gradient guides cm growth 
rostrally by binding Frz receptor on cm (fp - floor plate, rp - roof plate, cm - commissural axon, sc – spinal cord).  
 
how extracellular netrin exerted its chemoattractive effects 
on the neuron to direct growth.  
 Looking back to lessons from the elegant 
nematode, it was established that the unc-5 and unc-40 
genes, encoding for transmembrane proteins, were 
implicated in UNC-6 dependent growth cone guidance (8). 
We found that the vertebrate protein Deleted in Colorectal 
Cancer (DCC) is a homolog of UNC-40 expressed 
specifically on developing commissural axons (8). We felt 
certain DCC was the Netrin receptor when cells expressing 
recombinant DCC bound netrin-1. Moreover, when we 
blocked DCC’s extracellular domain using DCC blocking 
antibodies on dorsal spinal cord explants, a dose-dependent 
reduction in commissural axon outgrowth resulted (8). Thus, 
demonstrating that netrin mediates chemoattraction through 
DCC (Figure 1). We later showed that Netrin signal 
transduction through DCC depends on the cell-autonomous 
expression of heparan sulfate (HS), as evidenced by the 
commissural axon guidance deficits induced by Wnt-Cre 
driven axonal HS ablation in mice (9).  
Still, we did not know what prevented other neuron 
populations from being drawn to the Netrin signal when DCC 
expression extended laterally from commissural axons to 
sensory and motor neuron columns as well (8). We 
hypothesized that the second C. elegans transmembrane 
protein, UNC-5, may hold some of the answers as it was 
implicated in C. elegans growth cone repulsion (10). I in 
collaboration with the Stein lab at Yale, discovered two rat 
homologues of UNC-5, UNC5H1, and UNC5H2 are 
expressed lateroventrally in the embryonic rat spinal cord 
(10). We also found both UNC5H1 and UNC5H2 show high 
binding affinities for Netrin, and their expression co-localized 
with DCC in embryonic lateroventral neuron populations 
(10). The simultaneous expression of DCC and UNC5 on 
these axons confounded the probability that Netrin mediated 
attraction and repulsion separately through DCC and UNC5 
respectively. Thus, we hypothesized that UNC5 and DCC 
cytoplasmic domains interact to generate the repulsive 
effects of Netrin. We confirmed this hypothesis by producing 
chimeric forms of DCC and UNC5 receptors and blocking 
their cytoplasmic domains using specific antibodies (11). We 
found that an association between the UNC5 DCC binding 
(DB) domain and the DCC P1 domain mediate the 
conversion of Netrin attraction to repulsion (11; Figure 1). 
This helped explain the selective attraction of commissural 
axons to the ventral midline in spite of the diffuse Netrin 
gradient. 
 
The Commissure: A Role for Robo and Slit 
Now that we had a sense for how the commissural axons 
reached the ventral midline, the next obvious question 
became what signals them to cross and remain 
contralaterally. In a large scale Drosophila mutagenesis, the 
roundabout (Robo) gene was implicated in preserving the 
normal single projections of axons across the midline, by 
preventing their recrossing (12; Figure 1). Drs. Corey 
Goodman, Thomas Kidd and myself discovered that Robo 
was expressed most heavily on developing axon growth 
cones and filopodia in Drosophila, after they crossed the 
ventral midline (13). More importantly, we showed that Robo 
expression was conserved between fruit flies and mammals. 
Its transcripts were prevalent in the embryonic rat spinal cord 
and co-localized heavily with DCC expression (13). This 
suggested to us that an interaction occurs between the two 
receptors, but at the time, the ligand binding Robo remained 
unknown.  
 Within the next year, Dr.’s Goodman and Kidd 
identified the Robo receptor ligand in Drosophila as the Slit 
protein (14). I joined them to show evolutionary conservation 
of Slit among mammals (rats) in three isoforms, Slit-1, -2, 
and -3 (15). Slit and Robo transcript expression in the 
embryonic rat spinal cord overlapped heavily at the floor 
plate where commissural axons cross the ventral midline, as 
well as lateroventrally in the area of developing motor 
neuron columns (15). In support of our hypothesis that Slit 
acts as a chemorepellent through Robo, recombinant 
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expression of the Slit-2 isoform, which showed proteolytic 
processing, acted as a diffusible chemorepellent in vitro for 
developing motor axons (15). This explained motor axon 
repulsion as guided by both the Slit-Robo and Netrin-UNC5 
complexes, but failed to address (a) why commissural axons 
are not repelled from the ventral midline when they are 
potentially subject to Slit-Robo repulsion pre-commissure 
crossing, (b) nor what causes them to lose responsiveness 
to floor plate Netrin expression post-crossing and repel them 
rostrally in the spinal cord. 
 It was only in my more recent research that I 
stumbled across an answer to the first question with 
colleagues at the Howard Hughes Medical Institute. We 
discovered a divergent member of the Robo family of 
receptors that we have named Rig-1. Like other Robos, it 
binds Slits, but unlike other Robos, it is expressed more 
heavily on the pre-crossing portion of commissural axons 
(16). We developed a Rig-1 null mutant mouse line to 
investigate its role in commissural axon guidance. 
Interestingly, these mutant commissural axons showed 
premature responsiveness to Slit, which prevented crossing 
at the midline – a phenotype partially rescued by either 
removal of Slit or Robo-1 expression (16). Thus, we 
concluded that Rig-1 prevents premature Slit sensitivity to 
facilitate commissural axon guidance by Netrin toward the 
ventral midline (Figure 1).  
 To understand why commissural axons lose 
responsiveness to Netrin chemoattraction post-crossing, the 
Stein lab and I looked for a potential interaction between 
DCC and Robo in developing spinal axons of Xenopus. We 
learned that Robo activation by Slit silences Netrin mediated 
attraction, while maintaining Netrin’s neurotrophic effects 
(17). By developing chimeric Robo and DCC receptors with 
various cytoplasmic domain deletion constructs, we 
determined that this silencing occurs through direct binding 
of the Robo CC1 cytoplasmic domain to the DCC P3 domain 
(17).  
 
Post-Crossing Repulstion: SemaphorinIII & Slit 
To better understand guidance of commissural axons post-
crossing, I must take a step backward to introduce 
chemotropic factors that play a major role in patterning 
sensory axon growth. Corey Goodman and I discovered the 
expression of the chemorepulsive ligand SemaphorinIII 
(SemaIII) in the mammalian ventral spinal cord. SemaIII 
patterns sensory projections of the dorsal root ganglia that 
exit the spinal cord dorsally via chemorepulsion without 
inhibiting the ventral growth of commissural axons (18). 
Through expression cloning for SemaIII binding proteins in 
the embryonic rat spinal cord, I discovered the 
transmembrane protein Neuropilin. Through Neuropilin, 
SemaIII induces chemorepulsion and growth cone collapse 
(19).  
 As commissural axons lose responsiveness to 
chemoattractant forces post-crossing, however, it follows 
that they may also gain responsiveness to chemorepellent 
forces. Such is the role of Slit binding to Robo (14,15). This 
led me to investigate whether commissural axons gain 
responsiveness to SemaIII post-crossing as well. I found that 
post-crossing, but not pre-crossing axons were inhibited by 
recombinant expression of both SemaIII and Slit-2 (20). This 
indicated that expression of SemaIII by midline and 
nonmidline tissue functions in conjunction with Slit to prevent 
commissural axons from re-entering the midline post-
crossing (Figure 1). 
 
Morphogens Are Chemotropic Factors Too 
 Classical morphogens, such as Sonic Hedgehog (Shh) and 
Wnt, are molecules expressed in a developing organism that 
serve to pattern tissue differentiation according to their 
concentration along a gradient. Chemotropic molecules 
function in a similar fashion via diffusion to pattern axon 
growth. My previous research had shown that in the absence 
of Netrin or DCC, commissural axons generally failed to 
reach the ventral midline; still, a small population does (7). 
This suggested that other factors aid Netrin to guide their 
growth. Shh was a likely suspect in this case given its 
secretion by the floor plate. In collaboration with Elke Stein 
and Frederic Charron, I found that recombinant Shh 
expression in vitro caused commissural axon turning and 
that blocking its receptor, Smoothened, among Netrin-/- mice 
in vivo eliminated all attractant activity of the floor plate (21; 
Figure 1). Complementarily, my old postdoctoral colleague 
Jane Dodd showed that Bone Morphogenic Proteins (BMPs) 
expressed by the roof plate function to repel commissural 
axons from the dorsal spinal cord (22).  Morphogens also 
hold the key to why commissural axons turn rostrally after 
crossing the midline. I implicated a rostrally increasing Wnt 
gradient as a chemoattractive force guiding commissural 
axon growth towards the brain through the Frizzled receptor 
(23; Figure 1). The dual chemotropic and morphogenic roles 
of these molecules exemplify the functional conservation 
prevalent in all aspects of neuronal guidance.  In this model 
a single molecule serves multiple functions according to its 
spatiotemporal expression during development. 
 
Parallel Systems:  Guiding Vascularization 
 
Functional conservation provided the basis for my 
hypothesis that vascular growth could be guided by the 
same molecules as neuronal growth. In 2003, I made the 
move from my position as a Primary Investigator in 
academia to fill the administrative role as a Senior Vice 
President for the industrial biotech giant Genentech. This 
meant adapting and expanding my research focus to meet 
the therapeutic aims of the company.  
One of the foremost goals of Genentech is to 
identify therapeutic targets for cancer treatment. The growth 
of any tumor depends on the growth of new blood vessels 
into the tumor to provide a source of raw cellular materials 
and nutrition, a process termed angiogenesis. This growth of 
new vascular tissue suggested to me that chemotropic 
signaling molecules would be required to guide such growth. 
Throughout the human body, vascular and neuronal tissue 
form networks that run in parallel. More interestingly, they 
produce signals that mutually guide each other’s 
development (24).  Nerves produce vascular endothelial 
growth factor to guide vascular growth, while endothelial 
cells often produce neurotrophin-3 to attract axon outgrowth 
alongside the developing vasculature (24). As such, I have 
guided research at Genentech towards determining whether 
the chemotropic factors I helped to discover play similar 
roles in vascular morphogenesis.   
Unlike axons, which represent an extension of a 
single cell, vascular tissue is composed of many endothelial 
cells held together by cell adhesion molecules, such as 
integrins, expressed on their membranes. Thus, interruption 
of these cell-cell adhesions is critical for developing new 
vasculature. We have recently discovered that SemaIII plays 
a critical role in facilitating angiogenic plasticity by 
antagonizing integrin-mediated adhesion (25). Moreover, we 
found that these effects are transduced through the 
Neuropilin (Nrp) receptor, as in axon guidance (26). 
Although in addition to binding SemaIII, Nrp also binds 
VEGF on endothelial cells. To determine the role of Nrp in 
vascularization, we applied Nrp blocking antibodies to 
mouse retina and tumor models of vascular development 
(26). We found that blocking Nrp significantly reduces 
vascular density in both tissue types (26). Thus, SemaIII 
does not act as a chemorepellent to endothelial cells as it 
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does to neurons. Instead of inhibiting vascular growth, it 
seems to promote it by reducing cell-cell adhesion to 
facilitate reorganization of pre-existing vasculature (Figure 
2).  
In contrast to SemaIII, we found that the 
chemorepellent quality of Netrin signal transduction through 
UNC5b, an isoform of UNC5, was actually conserved (27, 
28, 29). Among mice and chicks, UNC5B expression was 
localized to arterial endothelial cells and sprouting 
angiogenic capillaries (28,29). In zebrafish, we learned that 
Netrin binding to UNC5B on endothelial filopodia causes 
filopodial retraction (27). Disruption of this interaction by 
knocking out UNC5B induced excessive angiogenesis (27). 
We further supported this Netrin-UNC5B mediated inhibition 
of sprouting angiogenesis among developing mouse and 
chick embryos (28, 29; Figure 2). All of these experiments 
point to UNC5B as a prospective anti-angiogenic target to 
prevent tumor growth. Moreover, they support the need for 
further research into the conserved role of chemotropic 
factors among vascular and neuronal networks.  
 
 
 
Figure 2. The Role of Chemotropic Factors in Guiding 
Vascularization. This model portrays the impact of SemaIII-Nrp and 
Netrin-UNC5B ligand-receptor complexes on vascular growth in a 
developing blood vessel. (1) SemaIII signaling through Nrp on 
endothelial cells interrupts cell-cell focal adhesion complexes to 
facilitate cell mobility that is necessary for vascular plasticity and 
outgrowth. (2) Netrin signaling through UNC5B repels endothelial 
filopodia to inhibit new vascular growth, termed sprouting 
angiogenesis. 
CNS Regeneration: Nogo and…Netrin? 
 
The most attractive, yet most elusive target for biotherapy is 
the mammalian central nervous system (CNS) due to the 
numerous innate roadblocks to regeneration present. Among 
these barriers are the numerous neuronal growth inhibitory 
molecules found in CNS myelin. Within the last five years, a 
subsection of my research has been dedicated toward 
investigating the role of the potent, CNS specific growth 
inhibitor Nogo in regeneration (30). Previous research 
showed that antibody blocking of Nogo function could 
stimulate CNS axonal recovery post-injury (31).   
My lab developed Nogo-A/B and Nogo-A/B/C 
knockout mice and performed spinal cord slice injuries on 
these mice to test their capacity for regeneration. My lab 
performed these experiments at the same time as the labs of 
my colleagues, Drs. M. Schwab and S. Strittmatter. Their 
Nogo knockout mice respectively showed either partial or 
complete corticospinal tract regeneration, while, at odds with 
their results, my Nogo knockout mice showed absolutely 
none (31, 32, 33). Distressed by these dissonant results, Dr. 
Strittmatter even graciously offered to have the member of 
his lab who performed the injuries do the same for ours. 
However, this still yielded the same results (31). I fortified the 
validity of these findings in a later study via genetic deletion 
of the Nogo receptor in vitro and via an in vivo mouse spinal 
cord injury model (34). In both cases, preventing Nogo’s 
growth inhibitory axons among injured neurons was 
ineffective at promoting regeneration (34). My lab’s recent 
research suggests that blocking Nogo function only induces 
acute growth cone collapse on an axon post-injury, while 
chronic growth inhibition could be attributed to other myelin 
inhibitors like Oligodendrocyte Myelin glycoprotein (OMgp) 
(35). This suggested that perhaps a more cumulative 
therapy targeting myelin growth inhibitors may show more 
promise to promote CNS regeneration.  
While my lab found that Nogo did not promote 
regeneration, it did show its promise in delaying the 
progression of neurodegeneration. In a mouse model of 
multiple sclerosis, Nogo-A vaccination generated an immune 
response that blunted behavioral signs of the disease, as 
well as reduced demyelination and axon damage associated 
with its progression (36). This points to a plausible role for 
targeting Nogo to treat the wide spectrum of 
neurodegenerative disorders prevalent in the ever-aging 
population.  
Within the last two years, my research into 
regeneration has led me to revisit the role of Netrin. I initially 
implicated Netrin as a repulsive cue that limits CNS 
remodeling post-injury. In mice, it plays this role by repelling 
adult neural stem cells away from the floor plate post-injury 
(37). However, even more recently, my lab found that Netrin 
plays a more broader role in preventing regeneration as a 
novel myelin based growth inhibitor, which transduces its 
inhibitory signal through UNC5 on spinal motor neurons (38). 
This only compounds the puzzle of regeneration by implying 
that other chemotropic factors may also function to promote 
or inhibit CNS regenerative growth.  
 
Conclusions 
 
Our discoveries of chemotropic receptor ligand complexes 
has allowed us to map an elementary path to commissural 
axon guidance (Figure 1). While we have implicated these 
molecules in axon guidance, we know so little of the 
downstream mechanisms transducing their signals. Nor 
have we investigated any potential differences in their 
functioning between the central and peripheral nervous 
systems. More relevant to our current research, we do not 
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know to what extent these molecules play parallel roles to 
pattern vascular growth. 
 Nonetheless, we have discovered that several of 
these molecules are functionally conserved in vascular 
growth (Figure 2). More importantly, knowledge of their 
function will help us develop new biotherapies to treat 
vascular diseases, such as the angiogenic process 
associated with tumor development. Additionally, our recent 
research into the potential for CNS regeneration, yet again, 
points to these chemotropic factors as therapeutic targets in 
cases of injury as well as neurodegenerative disease.  
 Much like Tiresias of Antigone, neurons and 
endothelial cells alike are blind to the fate of their growth. 
They require guidance, but they guide us too. The wisdom 
we have gained through learning of their growth has given 
birth to a new paradigm in development for how we explain 
cell migration and tissue patterning.  
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